文献速递腹部MR

混合型肝癌-胆管癌以HCC成分为主者生存更好且可基于MRI预测

Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction.
PubMed 文献 · Eur Radiol · 2022-09-16

本研究纳入107例病理确诊为单一cHCC-CCA的患者,通过ROC曲线确定HCC%预测总生存的最佳截断值为65%,并比较高低HCC%组的术前MRI特征。结果显示LI-RADS分类和血清CEA水平是HCC%的独立预测因素,可用于术前识别HCC%较高的cHCC-CCA患者。

要点

  • cHCC-CCA患者HCC成分>65%时总生存更好。
  • 术前MRI的LI-RADS分类与血清CEA水平可预测HCC%高低。
  • LI-RADS分类和CEA>5 ng/mL是HCC%的独立预测因素。

核心结论

  • cHCC-CCA患者HCC成分高于65%时总生存更好,术前MRI的LI-RADS分类和血清CEA水平有助于识别HCC%。

研究设计与样本

  • 回顾性研究纳入107例经病理确诊为单一cHCC-CCA的患者(依据2019 WHO分类),评估术前MRI特征和临床病理 findings。

诊断标准与关键数值

  • 基于总生存的ROC曲线确定HCC%最佳截断值为65%,据此51例(47.7%)归入高HCC%组。
  • LI-RADS分类为HCC%的预测因素(单变量OR=3.657,p=0.006;多变量OR=4.075,p=0.004)。
  • 血清CEA>5 ng/mL为HCC%的预测因素(单变量OR=0.348,p=0.089;多变量OR=0.298,p=0.040)。

临床应用与阅片要点

  • 术前可结合MRI的LI-RADS分类和血清CEA水平评估cHCC-CCA中HCC成分比例,辅助预后判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine the optimal cutoff value of HCC% for predicting the outcome of patients with combined hepatocellular carcinoma-cholangiocarcinoma (cHCC-CCA) and to investigate how preoperative MR features based on the Liver Imaging Reporting and Data System (LI-RADS ver. 2018) are related to the HCC% in cHCC-CCA.

METHODS: The study enrolled 107 patients pathologically confirmed to have single cHCC-CCA according to the 2019 WHO classification. A receiver operating characteristic (ROC) curve was used to find the optimal cutoff value of HCC% based on overall survival (OS). The preoperative MR imaging features and clinicopathological findings were retrospectively evaluated and compared between the high HCC% and low HCC% groups.

RESULTS: In total, 107 patients (mean age, males vs. females: 56.6 ± 10.7 years vs. 54.2 ± 12.8 years) were evaluated. Analysis of the relationship between HCC% and OS by ROC curve suggested that the optimal cutoff value was 65%, by which 51 (47.7%) patients were assigned to the high HCC% group. LI-RADS categorization (OR = 3.657, p = 0.006 vs. OR = 4.075, p = 0.004) and serum carcinoembryonic antigen (CEA) >5 ng/mL (OR = 0.348, p = 0.089 vs. OR = 0.298, p = 0.040) were significant predictors for HCC% in cHCC-CCA in both univariate and multivariate analysis.

CONCLUSIONS: cHCC-CCA patients with HCC components higher than 65% tend to exhibit better overall survival, and MRI-based LI-RADS categorization and serum CEA level are valuable for identifying HCC% in cHCC-CCA preoperatively.

KEY POINTS: • cHCC-CCA patients with HCC components higher than 65% tend to exhibit better overall survival. • MRI-based LI-RADS categorization and serum CEA level were significant predictors for HCC% in cHCC-CCA in both univariate and multivariate analyses and valuable for identifying HCC% in cHCC-CCA preoperatively.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Xiao, Zheng, Zhou, et al. Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction. Eur Radiol. 2022. PMID: 36112193. doi:10.1007/s00330-022-09131-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。